Medicare Enrolled

Dr. Rafael Rosa-Algarin, M.D.

Dermatology · Ocala, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
1750 SE 28TH LOOP, Ocala, FL 34471
3523514634
In practice since 2007 (18 years)
NPI: 1740482520 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosa-Algarin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosa-Algarin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosa-Algarin

Dr. Rafael Rosa-Algarin is a dermatology in Ocala, FL, with 18 years in practice. Based on federal Medicare data, Dr. Rosa-Algarin performed 8,779 Medicare services across 3,972 unique beneficiaries.

Between the years covered by Open Payments, Dr. Rosa-Algarin received a total of $994 from 8 pharmaceutical and/or device companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosa-Algarin is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 2% volume in FL$ $994 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,779
Medicare services
Top 2% in FL for dermatology
3,972
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~488 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)1,380$18$30
Office visit, established patient (30-39 min)792$89$198
Chronic care management, first 20 min/month762$46$98
Blood draw (venipuncture)366$7$8
Comprehensive metabolic blood panel318$10$33
Complete blood count (CBC) with differential301$8$24
Lipid panel (cholesterol and triglycerides)287$13$43
Automated urinalysis282$2$12
Urine microalbumin (protein) analysis218$6$17
Creatinine test (kidney function)218$5$17
Hemoglobin A1c test (diabetes monitoring)216$10$29
Thyroid stimulating hormone (TSH) test207$16$53
Apolipoprotein level202$21$35
Thyroid hormone, t3 measurement, free192$17$49
Free thyroxine (T4) test190$9$30
Uric acid level test170$4$14
Drug injection, under skin or into muscle153$10$40
Dexamethasone injection (steroid)131$0$3
Injection, ketorolac tromethamine, per 15 mg122$0$6
Magnesium level test121$7$17
C-reactive protein test (inflammation marker)119$5$20
Annual wellness visit, follow-up115$126$202
Annual depression screening112$18$28
Annual alcohol misuse screening, 5 to 15 minutes107$18$29
Glycated protein level105$16$36
Insulin measurement, total101$11$35
C-peptide (protein) level100$20$46
Phosphate level test99$5$8
Parathyroid hormone level test98$40$128
Vitamin B-12 level test87$15$47
Assessment of emotional or behavioral problems87$3$35
Vitamin D level test85$29$92
Folic acid level test83$14$46
Ldl cholesterol level71$10$32
Ferritin level test (iron stores)69$13$43
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage65$21$35
Office visit, established patient, complex (40-54 min)64$127$281
Flu vaccine administration63$30$35
Injection, methylprednisolone sodium succinate, up to 40 mg55$3$8
Lactate dehydrogenase (enzyme) level42$6$20
Iron binding capacity test38$9$28
Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique36$34$45
Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique36$34$45
Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets36$139$185
Infectious disease DNA/RNA test36$34$45
Electrocardiogram (EKG), 12-lead30$11$35
New patient office visit (45-59 min)29$96$262
Pneumonia vaccine administration28$30$35
Basic metabolic blood panel26$8$27
Transitional care management services for problem of high complexity20$214$429
Office visit, established patient (20-29 min)18$51$141
Pneumococcal vaccine, 13-valent17$253$275
Inhalation treatment for pneumonia14$24$45
Removal of impacted ear wax13$29$75
Homocysteine (amino acid) level12$18$35
Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus12$35$100
Pneumococcal vaccine, 23-valent12$131$135
Lipoprotein (a) level11$14$32
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$994
Total received (2018-2024)
Avg $166/year across 6 years
Top 29% in FL for dermatology
8
Companies
16
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$994 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$280
2023
$199
2022
$379
2021
$13
2020
$15
2018
$107

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$565
Amgen Inc.
$138
Bayer HealthCare Pharmaceuticals Inc.
$124
Daiichi Sankyo Inc.
$81
ABBVIE INC.
$31
Roche Diagnostics Corporation
$26
Smith+Nephew, Inc.
$15
Tactile Systems Technology Inc
$13
Top 3 companies account for 83.3% of total payments
Associated products mentioned in payments ›
CD cobas Reagents · EVENITY · Flexitouch Plus · Kerendia · Morphabond ER · Otezla · Santyl · VRAYLAR · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $11 per 100 Medicare services performed
Looking for a dermatology in Ocala?
Compare dermatologys in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
74
Per 100K population
19.1
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rosa-Algarin is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and low-engagement industry engagement, with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Rosa-Algarin experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Rosa-Algarin performed 1,380 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rosa-Algarin receive payments from pharmaceutical companies?
Yes. Dr. Rosa-Algarin received a total of $994 from 8 companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rosa-Algarin's costs compare to other dermatologys in Ocala?
Dr. Rosa-Algarin's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rosa-Algarin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →